logo
Airbus Stock (NASDAQ:EADSY) Notches Up With New Interest in Long-Range Aircraft

Airbus Stock (NASDAQ:EADSY) Notches Up With New Interest in Long-Range Aircraft

Aircraft maker Airbus (EADSY) occupies an interesting position in the aircraft market as, effectively, part of a duopoly with Boeing (BA). And there is a new development that Airbus has seen coming from the Asian market that bears watching. There is a growing interest in long-range aircraft, to the point where some airlines are changing previous orders to the longer-range breed. That left investors considering the matter further, and gave Airbus a fractional boost in Thursday afternoon's trading.
Don't Miss TipRanks' Half-Year Sale
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
The reports note that AirAsia is currently talking to Airbus about converting an order for narrow-body aircraft to an order for A321XLR models instead. AirAsia is a budget airline that is currently in the midst of restructuring, reports note, so a certain amount of change in its property, plant, and equipment priorities makes some sense.
AirAsia is currently working to complete a financial reorganization, but was also in talks to buy another 50 to 70 Airbus aircraft within the next three months. In fact, reports note, AirAsia currently has outstanding orders with Airbus of over 350 planes in total. There was also a potential order for a hefty quantity of A220 planes—a smaller aircraft overall—but those have been pushed aside for now. Given that Airbus has a production backlog of over 8,500 aircraft, it is a safe bet that AirAsia's planes are nowhere near production just yet. Changing the order accordingly might be within possibility.
The Unexpected COMAC Revival
The Boeing / Airbus duopoly has been somewhat shaky for some time now. There are, after all, other aircraft makers out there. Embraer (ERJ), for instance, is a thing, though nowhere near on either Boeing or Airbus' scale. But then there is COMAC, the Commercial Aircraft Corporation of China. While this darkest of horses has been in the background for years, it recently made a move that may turn the duopoly into a triumvirate…someday.
Air China (AIRYY), just Tuesday, launched its first international service flight using a COMAC C909 aircraft. The C909 is generally regarded as a regional aircraft, with seating that generally runs between 78 and 90. It is a smaller aircraft, but for regional flights that have shorter turnaround times, such aircraft are not out of line. The flight ran 90 minutes, from Hohhot in northern China to Ulaanbaatar in Mongolia, but still represented a major step forward for COMAC's ambitions.
Is Airbus Stock a Good Buy Right Now?
Turning to Wall Street, analysts have a Moderate Buy consensus rating on EADSY stock based on one Buy assigned in the past three months, as indicated by the graphic below. After a 40.08% rally in its share price over the past year, the average EADSY price target of $38.80 per share implies 25.15% downside risk.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Oil Rises Amid Hopes for U.S.-EU Trade Agreement
Oil Rises Amid Hopes for U.S.-EU Trade Agreement

Wall Street Journal

time25 minutes ago

  • Wall Street Journal

Oil Rises Amid Hopes for U.S.-EU Trade Agreement

0006 GMT — Oil rises in the early Asian trade. U.S. and EU officials look like they are converging on a possible deal, after the White House's agreement with Tokyo earlier in the week. European officials expect a 15% tariff on most EU exports to the U.S., in line with the Japan deal. This news has lifted confidence that a worst-case scenario of a 30% tariff is avoidable, ANZ Research analysts say in a research report. Positive sentiment has also been supported by technical-related buying, the analysts add. Front-month WTI crude oil futures are 0.3% higher at $66.21/bbl; front-month Brent crude oil futures are 0.3% higher at $69.36/bbl. (

Exploring High Growth Tech Stocks In Asia July 2025
Exploring High Growth Tech Stocks In Asia July 2025

Yahoo

timean hour ago

  • Yahoo

Exploring High Growth Tech Stocks In Asia July 2025

As global markets experience a mix of gains and losses, with the S&P 500 Index and Nasdaq Composite reaching new highs supported by solid corporate earnings, Asian tech stocks are drawing attention amid these shifting dynamics. In this environment, identifying high-growth opportunities often involves looking at companies that demonstrate strong innovation potential and resilience to economic fluctuations. Top 10 High Growth Tech Companies In Asia Name Revenue Growth Earnings Growth Growth Rating Suzhou TFC Optical Communication 30.23% 29.66% ★★★★★★ Gold Circuit Electronics 20.76% 25.89% ★★★★★★ Shanghai Huace Navigation Technology 24.51% 23.48% ★★★★★★ Fositek 30.43% 37.34% ★★★★★★ Shengyi Electronics 26.23% 37.40% ★★★★★★ eWeLLLtd 24.95% 24.40% ★★★★★★ Global Security Experts 20.56% 28.04% ★★★★★★ CARsgen Therapeutics Holdings 81.53% 96.08% ★★★★★★ Marketingforce Management 27.79% 111.80% ★★★★★★ JNTC 55.45% 94.52% ★★★★★★ Click here to see the full list of 480 stocks from our Asian High Growth Tech and AI Stocks screener. Below we spotlight a couple of our favorites from our exclusive screener. Meitu Simply Wall St Growth Rating: ★★★★☆☆ Overview: Meitu, Inc. is an investment holding company that develops and provides products for photo, video, and design production along with other AI-powered solutions in Mainland China and internationally, with a market cap of approximately HK$51.05 billion. Operations: The company generates revenue primarily from its Internet Business segment, which reported CN¥3.34 billion. Meitu, a player in the Interactive Media and Services industry in Asia, has demonstrated robust growth with earnings soaring by 112.8% over the past year, significantly outpacing its industry's growth rate of 6.8%. This surge is partly due to a substantial one-off gain of CN¥222.9M, which skews the earnings quality but underscores potential volatility in profit figures. On the innovation front, Meitu's commitment to research and development is evident from its latest strategic moves including a significant private placement aimed at raising $250 million through convertible bonds. This influx of capital is poised to bolster their technological advancements and expand their digital services footprint, ensuring they stay competitive in a fast-evolving sector where annual revenue growth has reached 18.7%, outperforming the broader Hong Kong market's growth rate of 8%. Get an in-depth perspective on Meitu's performance by reading our health report here. Explore historical data to track Meitu's performance over time in our Past section. Beijing Wantai Biological Pharmacy Enterprise Simply Wall St Growth Rating: ★★★★★☆ Overview: Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is a company engaged in the development, production, and sale of biological products with a market cap of CN¥76.87 billion. Operations: Beijing Wantai Biological Pharmacy Enterprise focuses on developing, producing, and selling biological products. The company's revenue model is driven by its diverse portfolio in the healthcare sector. Despite recent challenges, including its removal from the Shanghai Stock Exchange 180 Value Index, Beijing Wantai Biological Pharmacy Enterprise shows potential in a volatile market. The company's revenue is expected to grow by 27.7% annually, outpacing the broader Chinese market's growth rate of 12.4%. However, it currently faces profitability issues with a significant shift from a net income of CNY 125.71 million to a net loss of CNY 52.78 million as reported in Q1 2025. This downturn reflects short-term struggles but also underscores an aggressive pursuit for growth in biotech innovation and development sectors, where it aims to stabilize and eventually profit within the next three years with an anticipated earnings growth rate of 105.82% per year. Click here to discover the nuances of Beijing Wantai Biological Pharmacy Enterprise with our detailed analytical health report. Evaluate Beijing Wantai Biological Pharmacy Enterprise's historical performance by accessing our past performance report. Shenzhen Longsys Electronics Simply Wall St Growth Rating: ★★★★★☆ Overview: Shenzhen Longsys Electronics Co., Ltd. is involved in the research, development, design, packaging, testing, manufacturing, and sales of semiconductor storage application products with a market cap of CN¥35.96 billion. Operations: Longsys specializes in semiconductor storage application products, focusing on research, development, design, and manufacturing. The company operates across various stages of the production process including packaging and testing. Shenzhen Longsys Electronics has demonstrated a robust commitment to innovation, particularly in the automotive technology sector. With an annual revenue growth projected at 20.5% and an impressive earnings forecast to surge by 61.73% annually, the company is strategically positioning itself in high-growth areas like AI-powered cockpits and connected vehicles. Despite a recent net loss of CNY 151.81 million in Q1 2025, Longsys continues to invest heavily in R&D, ensuring its products meet stringent AEC-Q100 reliability standards and support critical functions across various applications. This forward-looking approach is exemplified by their latest offerings at Auto Shanghai 2025, including advanced automotive-grade storage solutions that cater to next-generation smart vehicles' needs. Dive into the specifics of Shenzhen Longsys Electronics here with our thorough health report. Gain insights into Shenzhen Longsys Electronics' historical performance by reviewing our past performance report. Where To Now? Click here to access our complete index of 480 Asian High Growth Tech and AI Stocks. Are you invested in these stocks already? Keep abreast of every twist and turn by setting up a portfolio with Simply Wall St, where we make it simple for investors like you to stay informed and proactive. Simply Wall St is your key to unlocking global market trends, a free user-friendly app for forward-thinking investors. Seeking Other Investments? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SEHK:1357 SHSE:603392 and SZSE:301308. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

US chip maker Intel says revenue rose as it cut ranks
US chip maker Intel says revenue rose as it cut ranks

Yahoo

time2 hours ago

  • Yahoo

US chip maker Intel says revenue rose as it cut ranks

Intel on Thursday posted quarterly revenue that topped market expectations, saying it has cut about 15 percent of its workforce to be "more agile." The US chip maker also said it "will no longer move forward" with projects in Germany and Poland as part of a push to save billions of dollars. The struggling chip maker's earnings report came as rivals specializing in graphics processing units (GPUs) for artificial intelligence thrive due to rapid adoption of the technology. Intel is one of Silicon Valley's most iconic companies, but its fortunes have been eclipsed by Asian powerhouses TSMC and Samsung, which dominate the made-to-order semiconductor business. The company was also caught by surprise with the emergence of Nvidia as the world's preeminent AI chip provider. Intel's niche has been in chips used in traditional computing processes, steadily being eclipsed by the AI revolution. Intel reported $12.9 billion in sales in the recently ended quarter, topping forecasts, but logged a $2.9 billion loss that included $1.9 billion in restructuring charges. "Intel has completed the majority of the planned headcount actions it announced last quarter to reduce its core workforce by approximately 15 percent," the company said in an earnings release. "These changes are designed to create a faster-moving, flatter and more agile organization." Intel shares were down slightly in after-hours trades that followed the release of the earnings figures. Intel chief executive Lip-Bu Tan took the helm in March, announcing layoffs as White House tariffs and export restrictions muddied the market. Malaysia-born tech industry veteran Tan has said it "won't be easy" to overcome challenges faced by the company. gc/aks

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store